Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gaming For Attention: FDA Grants De Novo For Novel ADHD Treatment

Akili Interactive’s EndeavorRx has opened the door for other digital therapies to get to market faster

Executive Summary

A new video game pediatric ADHD treatment has opened the door for other such novel therapies to come to market using the less stringent 510(k) pathway, as interest in such products have gained significant steam over the past few years.

You may also be interested in...



Hub-And-Spoke Pioneer PureTech's Strategy Paying Off

The concept of a parent company with operating subsidiaries is becoming increasing common in biotech. The first to do it, Daphne Zohar, who co-founded PureTech back in 2005, tells Scrip how the company has made that model work.

OTC Digital Health Technology Companies Noom, Hello Heart Score Additional Funding

Akili Interactive, Hello Heart and Noom announced new funding rounds today, proving that investors’ strong appetite for companies that are part of the digital transformation in health care.

Winners: Digital Health Companies Noom, Akili, Hello Heart Scored New Funding

Akili Interactive, Hello Heart and Noom announced new funding rounds today, proving that investors’ strong appetite for companies that are part of the digital transformation in health care.

Related Content

Topics

UsernamePublicRestriction

Register

MT142297

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel